PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
MGNX vs. SPLG
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between MGNX and SPLG is 0.33, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.3

Performance

MGNX vs. SPLG - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in MacroGenics, Inc. (MGNX) and SPDR Portfolio S&P 500 ETF (SPLG). The values are adjusted to include any dividend payments, if applicable.

-40.00%-30.00%-20.00%-10.00%0.00%10.00%AugustSeptemberOctoberNovemberDecember2025
-40.54%
5.24%
MGNX
SPLG

Key characteristics

Sharpe Ratio

MGNX:

-0.60

SPLG:

1.89

Sortino Ratio

MGNX:

-0.14

SPLG:

2.53

Omega Ratio

MGNX:

0.97

SPLG:

1.35

Calmar Ratio

MGNX:

-0.76

SPLG:

2.83

Martin Ratio

MGNX:

-1.03

SPLG:

11.90

Ulcer Index

MGNX:

68.34%

SPLG:

2.01%

Daily Std Dev

MGNX:

116.85%

SPLG:

12.63%

Max Drawdown

MGNX:

-94.40%

SPLG:

-54.52%

Current Drawdown

MGNX:

-92.44%

SPLG:

-3.93%

Returns By Period

In the year-to-date period, MGNX achieves a -6.46% return, which is significantly lower than SPLG's -0.67% return. Over the past 10 years, MGNX has underperformed SPLG with an annualized return of -20.99%, while SPLG has yielded a comparatively higher 13.31% annualized return.


MGNX

YTD

-6.46%

1M

-5.00%

6M

-43.55%

1Y

-71.59%

5Y*

-23.56%

10Y*

-20.99%

SPLG

YTD

-0.67%

1M

-3.35%

6M

3.75%

1Y

23.76%

5Y*

13.79%

10Y*

13.31%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

MGNX vs. SPLG — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MGNX
The Risk-Adjusted Performance Rank of MGNX is 2222
Overall Rank
The Sharpe Ratio Rank of MGNX is 1717
Sharpe Ratio Rank
The Sortino Ratio Rank of MGNX is 3131
Sortino Ratio Rank
The Omega Ratio Rank of MGNX is 2929
Omega Ratio Rank
The Calmar Ratio Rank of MGNX is 66
Calmar Ratio Rank
The Martin Ratio Rank of MGNX is 2525
Martin Ratio Rank

SPLG
The Risk-Adjusted Performance Rank of SPLG is 8282
Overall Rank
The Sharpe Ratio Rank of SPLG is 8282
Sharpe Ratio Rank
The Sortino Ratio Rank of SPLG is 8080
Sortino Ratio Rank
The Omega Ratio Rank of SPLG is 8282
Omega Ratio Rank
The Calmar Ratio Rank of SPLG is 8282
Calmar Ratio Rank
The Martin Ratio Rank of SPLG is 8484
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

MGNX vs. SPLG - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for MacroGenics, Inc. (MGNX) and SPDR Portfolio S&P 500 ETF (SPLG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for MGNX, currently valued at -0.60, compared to the broader market-2.000.002.00-0.601.89
The chart of Sortino ratio for MGNX, currently valued at -0.14, compared to the broader market-4.00-2.000.002.004.00-0.142.53
The chart of Omega ratio for MGNX, currently valued at 0.97, compared to the broader market0.501.001.502.000.971.35
The chart of Calmar ratio for MGNX, currently valued at -0.76, compared to the broader market0.002.004.006.00-0.762.83
The chart of Martin ratio for MGNX, currently valued at -1.03, compared to the broader market-30.00-20.00-10.000.0010.0020.00-1.0311.90
MGNX
SPLG

The current MGNX Sharpe Ratio is -0.60, which is lower than the SPLG Sharpe Ratio of 1.89. The chart below compares the historical Sharpe Ratios of MGNX and SPLG, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.004.00AugustSeptemberOctoberNovemberDecember2025
-0.60
1.89
MGNX
SPLG

Dividends

MGNX vs. SPLG - Dividend Comparison

MGNX has not paid dividends to shareholders, while SPLG's dividend yield for the trailing twelve months is around 1.29%.


TTM20242023202220212020201920182017201620152014
MGNX
MacroGenics, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
SPLG
SPDR Portfolio S&P 500 ETF
1.29%1.28%1.44%1.69%1.25%1.54%1.79%2.23%1.75%1.97%1.98%1.79%

Drawdowns

MGNX vs. SPLG - Drawdown Comparison

The maximum MGNX drawdown since its inception was -94.40%, which is greater than SPLG's maximum drawdown of -54.52%. Use the drawdown chart below to compare losses from any high point for MGNX and SPLG. For additional features, visit the drawdowns tool.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%AugustSeptemberOctoberNovemberDecember2025
-92.44%
-3.93%
MGNX
SPLG

Volatility

MGNX vs. SPLG - Volatility Comparison

MacroGenics, Inc. (MGNX) has a higher volatility of 12.24% compared to SPDR Portfolio S&P 500 ETF (SPLG) at 4.56%. This indicates that MGNX's price experiences larger fluctuations and is considered to be riskier than SPLG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%AugustSeptemberOctoberNovemberDecember2025
12.24%
4.56%
MGNX
SPLG
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab